Mile High Peptides

09/01/2026

🔬 What Happens When Two Pathways Become Three?

Yesterday we explored dual-receptor research. Today, we’re adding a third pathway.

🧬 Retatrutide is an investigational triple receptor agonist designed to activate:
GLP-1 + GIP + Glucagon
Why is that scientifically interesting?

Instead of investigating one metabolic signaling pathway—or even two—researchers can examine what happens when three distinct receptor systems are engaged within the same investigational approach.

That makes Retatrutide an important subject in the evolving study of multi-receptor metabolic signaling and raises a bigger research question:

🔬 How does triple-receptor signaling differ from single- and dual-receptor approaches?

Three pathways. One fascinating research question.

🧬 Day 3 of MHP Metabolic Research Week
Tomorrow: Survodutide — why are researchers investigating GLP-1 + glucagon together?

📚 Explore the science and continue your research:
www.milehighpeptides.com/education-hub

Educational content for research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.

08/31/2026

🔬 Why Target Two Receptors Instead of One?

Yesterday we looked at GLP-1, GIP and glucagon individually. Today, we’re looking at what happens when research brings two pathways together.

🧬 Tirzepatide is a dual GIP + GLP-1 receptor agonist that has become an important subject in metabolic research.
Rather than focusing exclusively on GLP-1 receptor signaling, tirzepatide provides researchers with a model for investigating how simultaneous GIP and GLP-1 receptor activity may influence interconnected metabolic pathways.
That’s what makes dual-receptor research so interesting: it’s not simply about adding another target—it’s about understanding how the signaling pathways interact.

Two receptors. One compound. A different research question.

🔬 Day 2 of MHP Metabolic Research Week

Tomorrow: Retatrutide — what changes when research moves from TWO receptor targets to THREE?

📚 Continue exploring the science at:
www.milehighpeptides.com/education-hub
Educational content for research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.

08/30/2026

🔬 GLP-1 vs. GIP vs. Glucagon: Three Pathways. Different Roles.

You’ve probably heard GLP-1 mentioned—but what about GIP and glucagon?

These three signaling pathways play distinctly different roles in metabolic research, which is why scientists are increasingly interested in what happens when compounds target one, two, or even all three receptors.

🧬 GLP-1 — studied for its role in glucose-dependent insulin signaling, gastric emptying and satiety signaling.

🔬 GIP — another incretin pathway involved in glucose-dependent insulin signaling and broader metabolic processes.

⚗️ Glucagon — plays an important role in hepatic glucose regulation and energy mobilization.

Understanding these pathways provides the foundation for understanding why compounds such as tirzepatide, retatrutide, survodutide and mazdutide are generating so much research interest.

This is Day 1 of MHP Metabolic Research Week. Tomorrow, we take a closer look at Tirzepatide and dual GIP/GLP-1 receptor research.

📚 Want to go deeper into the science? Explore research articles, compound information and educational resources at:
www.milehighpeptides.com/education-hub

For laboratory research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.

08/29/2026

🔬 ARA-290: A Research Spotlight on Cellular Repair Signaling

ARA-290—also studied under the name cibinetide—is a peptide-derived compound attracting scientific interest for its interaction with the Innate Repair Receptor.

Preclinical and clinical research has explored how this signaling pathway may influence inflammatory responses, cellular protection, and tissue-repair processes without stimulating red-blood-cell production. Research remains ongoing, making ARA-290 an intriguing subject for laboratories studying cellular stress and repair signaling.
Want to take a closer look at this emerging research compound?
Explore ARA-290 and visit our Education Hub at www.milehighpeptides.com/education-hub.
For laboratory research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.

08/28/2026

SERMORELIN: A RESEARCH SPOTLIGHT 🔬
What makes Sermorelin relevant to peptide research?
Sermorelin is a synthetic peptide analog corresponding to the first 29 amino acids of naturally occurring growth hormone–releasing hormone, commonly known as GHRH.
In controlled laboratory settings, researchers investigate Sermorelin’s interaction with GHRH receptors, peptide signaling pathways, pituitary response mechanisms and endocrine research models.
Its defined amino-acid sequence makes it an important compound for researchers exploring receptor-mediated signaling and biological feedback mechanisms.
Explore Sermorelin product information and available research documentation from Mile High Peptides LLC.
VISIT: www.milehighpeptides.com
For research use only. Not for human or veterinary use. This content is provided for educational purposes only.

08/28/2026

Meet Your New Peptide Skincare Power Duo ✨
Two formulas. One elevated routine.
CopperLift Renewal Serum and CopperLift Renewal Cream pair copper tripeptide GHK-Cu with carefully selected skincare ingredients to help hydrate, soften and improve the appearance of smoother, firmer-looking skin.
Begin with the lightweight serum, then layer on the cream to seal in lasting moisture. Use them together for a complete morning and evening peptide skincare ritual—or purchase each formula individually.
✨ Peptide-powered skincare ✨ Supports a smoother, firmer-looking appearance ✨ Helps replenish essential hydration ✨ Serum and cream available individually
Ready to upgrade your skincare routine? Shop CopperLift Renewal now at www.milehighpeptides.com.

08/27/2026

08/26/2026

Why Is Everyone Talking About Cagrilintide? 👀

Everyone knows about GLP-1 research, but Cagrilintide is bringing attention to a different pathway.

Cagrilintide works with amylin, a natural hormone connected to appetite, feelings of fullness, and how the body responds to food.
That difference is exactly why Cagrilintide has become such an interesting topic in newer metabolic research.

Different pathway. Different research. 🔬

Curious about Cagrilintide? Explore more at MileHighPeptides.com

08/25/2026

Ipamorelin Research: What Are Scientists Investigating?

Ipamorelin is studied in controlled laboratory and preclinical models involving growth hormone secretagogue receptor activity, related signaling pathways, metabolic pathways, and cellular research models.

Explore detailed product and research information from Mile High Peptides.

Visit milehighpeptides.com

08/24/2026

What happens when two research peptides are studied together? 🔬
Meet Wolverine Blend — BPC-157 + TB-500.
Researchers study BPC-157 and TB-500 through different biological pathways.
BPC-157 is commonly investigated in laboratory research involving tissue-response mechanisms, connective-tissue biology and cellular signaling.
TB-500 is studied for its involvement in cell migration, tissue remodeling and regenerative processes.
Putting the two compounds into the same controlled research system allows researchers to investigate how different repair-related pathways interact.
Curious about the science behind Wolverine Blend?
Explore research compounds from Mile High Peptides LLC.

Research Use Only: Products discussed are intended strictly for laboratory research and in vitro use only. They are not intended for human consumption, clinical use, diagnostic use, therapeutic use, or veterinary applications.